✦ LIBER ✦

PO38 Re-treatment versus rituximab maintenance therapy at progression in patients with follicular lymphoma

✍ Scribed by D. Dukovski; S. Trajkova; I. Panovska-Stavridis; A. Stojanovik; L. Cevreska

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab Maintenance Therapy Until Prog

✍ Yared, Jean; Kimball, Amy; Baer, Maria R.; Bahrain, Huzefa; Auerbach, Michael 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 281 KB

PCN29 COST-EFFECTIVENESS OF MAINTENANCE

✍ F Kasteng; M Erlanson; H Hagberg; E Kimby; T Relander; J Lundkvist 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

EC4 COST-EFFECTIVENESS AND COST-UTILITY

✍ A Pacull; C Coudray-Omnes; P Brice; E Deconinck; C Le Pen; H Miadi-Fargier 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

9200 Phase II study of IPH1101 (with low

✍ Casasnovas, O.; Thieblemont, C.; Rossi, J.F.; Sicard, H.; Ingoure, S.; Audibert, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

High dose therapy and autologous stem ce

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB